Navigation Links
A 15p increase in an NHS Prescription Cost

The cost of an NHS prescription in England is in for a raise, and slated to go up by 15p, much below the inflation rate, with effect from April, 2006. // The cost of a prescription now will be £6.65, and this increase will give the NHS nearly £430m extra in revenue.

The charge for a prescription prepayment certificate will also be up by 75p - to £34.65 for a period of four months, and by £2.10 to £95.30 for 12 months.

Health Minister Jane Kennedy, explaining the cost revision, said "For the eighth consecutive year we have held the increase to below or around the level of inflation.

This is a modest increase, which will help maintain the contribution that charges make towards the cost of the NHS."

According to Ms Kennedy, nearly 87% of prescription items are given free because of the exemption system in practice. And nearly 50% of the population is eligible for free NHS prescriptions. Also, prescription prepayment certificates are a means of cost saving, as those interested can procure all the prescriptions required for £2 per week.

John D'Arcy, of the National Pharmacy Association, who is in favor of the system being abolished, said "The system is not only complex, but also riddled with inequities. The Association believes that prescription charges deter many people from getting their prescriptions filled, while many ask their pharmacist for guidance on which medicines they need most when it contains several items."

'"/>




Page: 1

Related medicine news :

1. Mortality increased in Sporting enthusiasts!
2. Tattoos may significantly increase risk of hepatitis C infection
3. Human gene number increases
4. Stress response increases suicide risk
5. Sleep apnoea increases post-operative risks
6. Long travel increase pulmonary embolism
7. Antidepressants increase gastric bleeding
8. Strokes increased during squatting
9. Vaginosis increases risk of miscarriage
10. Asthmatics at increased risk of lung cancer
11. Serotonin increases stroke risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: